Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
patent lawsuits
Pharma
Enhertu, Akeso, Fujifilm-Regeneron—Fierce Pharma Asia
Enhertu delivered a positive readout in first-line breast cancer. Akeso's ivonescimab bagged another phase 3 win. Fujifilm signed a 10-year deal with Regeneron.
Angus Liu
Apr 25, 2025 8:45am
Halozyme sues Merck over subcutaneous Keytruda
Apr 24, 2025 2:41pm
GSK, Pfizer end RSV patent feud amid vaccine market uncertainty
Apr 4, 2025 10:55am
Merck, Halozyme dig in for patent fight over injectable Keytruda
Mar 6, 2025 11:18am
Novartis filed patent lawsuits in defense of radiopharma meds
Nov 4, 2024 10:48am
Exelixis stock rises as Cabometyx withstands patent challenge
Oct 16, 2024 10:37am